Oncology Pharma, Inc. Update on PCAOB Audit Selection Process and License Agreement

October 12, 2021 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / October 12, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") would like to update investors on its progress. The Company is in the final stages of engaging with a PCAOB Audit firm to support its effort to meet one of the necessary steps to qualify for the capital markets tier of the NASDAQ exchange. The Company is committed to complete its process and select a firm to conduct this...

Read more

Announcement from Biovica International's Extra General Meeting

October 12, 2021 7:45 AM

UPPSALA, SE / ACCESSWIRE / October 12, 2021 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II)The extra general meeting of Biovica International AB ("Biovica" or the "Company") was held today on 12 October 2021 and the following resolutions were passed by the meeting.ELECTION OF THE BOARD OF DIRECTORSThe extra general meeting resolved that the board of directors shall consist of eight directors without deputy directors.It was...

Read more

RepliCel Life Sciences Appoints One of Japan's Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor

October 12, 2021 6:00 AM

Kunihiko Suzuki, one of the leading pioneers in Japan's emerging regenerative medicine industry, commits to a role as Senior Strategic Advisor to RepliCel's Board of DirectorsVANCOUVER, BC / ACCESSWIRE / October 12, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that Kunihiko Suzuki has...

Read more

Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates

October 7, 2021 4:05 PM

Revenue expected between $16.0 million and $16.4 millionThird consecutive quarter of double-digit revenue growth; endoscopic suturing up over 30%Submitted a De Novo 510(k) Classification Request to FDA for Apollo ESG™ for weight loss and Apollo REVISE™ for prior bariatric surgery revisionsPrincipal investigators expected to present primary efficacy and safety endpoints from MERIT study in late OctoberAUSTIN, TX / ACCESSWIRE / October...

Read more

Black Bird Biotech Launches MiteXstream(TM) Online Store for Direct Sales to Commercial and Home Users

October 7, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / October 7, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, announced today that it has launched an online store for its game-changing biopesticide, MiteXstreamTM, to facilitate direct sales to commercial and home users. The new www.mitexstream.com website has been redesigned to better handle traffic driven to it by BBBT's marketing efforts within the dynamic...

Read more

ITOCO is pleased to present its Carbon Capture Offset program to the upcoming COP26 Conference in Glasgow, United Kingdom.

October 7, 2021 7:45 AM

TORONTO, ON / ACCESSWIRE / October 7, 2021 / ITOCO INC. (OTC Pink:ITMC) ITOCO representatives will be presenting to and attending the meeting session COP 26, Glasgow, UK, from 25 Oct 2021 to 12 Nov 2021.COP26 is the annual United Nations Climate Change Conference. It is the largest Conference of its type in the world. The climate talks will be the largest international summit ever held in the UK, bringing together heads of state, climate experts...

Read more

Mosaic ImmunoEngineering Expands Immuno-Oncology Platform Through New Technology Licensing Agreement with the University of California San Diego

October 6, 2021 8:00 AM

- Nanoparticle-based technology complements the company's intratumoral technology platform -NOVATO, CA / ACCESSWIRE / October 6, 2021 / Mosaic ImmunoEngineering, Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases, today announced that it has licensed rights to develop and...

Read more

Pieris Pharmaceuticals Announces Appointments of Chief Financial Officer and Chief Business Officer

October 6, 2021 8:00 AM

BOSTON, MA / ACCESSWIRE / October 6, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, today announced the promotions of Thomas Bures to Chief Financial Officer and Ahmed Mousa to Chief Business Officer."Since joining Pieris four years ago, Tom has demonstrated...

Read more

Germany Approves Novel Cell Therapy Extracted from Skin

October 6, 2021 3:50 AM

Germany's Federal Institute for Vaccines and Biomedicines (Paul-Ehrlich-Institut) grants RHEACELL national approval for its cell therapy product AMESANAR(R) for the use in patients with chronic woundsHEIDELBERG, GERMANY / ACCESSWIRE / October 6, 2021 / Chronic wounds not only put great strain on the health system, but also have a major impact on the quality of life of affected patients.RHEACELL, a German biopharmaceutical company focused on...

Read more

Biogravity LLC Opens Microgravity-Focused Laboratory at WMU Innovation Center

October 5, 2021 2:50 PM

INNOVATIONS IN BIOTECH AND CELL DISCOVERY TO USE GRAVITATIONAL UNLOADINGKALAMAZOO, MI / ACCESSWIRE / October 5, 2021 / Newly launched microgravity startup www.BioGravityLLC.com has opened their lab at the Western Michigan University Homer Stryker M.D. School of Medicine Innovation Center.Touted as a place to start and grow life science, technology, and engineering ventures, the WMU Innovation Center integrates 69,000-square-feet of purpose-built...

Read more

Lexaria Oral Nicotine Study NIC-A21-1 Delivers Outstanding Results

October 5, 2021 9:05 AM

DehydraTECH-oral nicotine delivery peaked in bloodstream 10x to 20x faster than controlsPeak levels achieved were up to 10x higher than controlsKELOWNA, BC / ACCESSWIRE / October 5, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that its recent oral nicotine absorption study NIC-A21-1 revealed that DehydraTECHTM-nicotine delivered via...

Read more

Black Bird Biotech Retires Three Separate Convertible Notes with Cash Repayments

October 5, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / October 5, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, announced today that it has repaid approximately $225,000 in remaining indebtedness under three separate convertible notes with cash payments. BBBT's move served to protect shareholders from a potentially significant market overhang attributable to below-market conversion rates."We took on these...

Read more

CB Scientific, Inc. (CBSC) Announces the Engagement of MaloneBailey, LLP

October 5, 2021 6:00 AM

CBSC begins independent Financial Audit through MaloneBailey, LLP.ESCONDIDO, CA / ACCESSWIRE / October 5, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or the "Company") is a provider of remote ECG cardiac monitoring products and services; simple wearable solutions for detecting potentially life-threatening heart arrhythmias in patients with heart-related issues, both domestically and internationally.The company has announced that they have...

Read more

Applied UV Continues Successful International Expansion with Installations of Airocide(R) Systems at Multiple Wineries in Mexico

October 4, 2021 8:30 AM

Exclusive distributor has recently installed Airocide® units to help protect winemaking operationsMOUNT VERNON, NY / ACCESSWIRE / October 4, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and...

Read more

BioInvent and Transgene to present preclinical data on BT-001 oncolytic virus at SITC 2021

October 1, 2021 9:15 AM

LUND, SE / ACCESSWIRE / October 1, 2021 / BioInvent International (STO:BINV)BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, and Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announce that they...

Read more

Upcoming Presentation at the World Molecular Imaging Congress to Highlight Mosaic ImmunoEngineering’s Lead Immuno-Oncology and Modular Vaccine Platform COVID-19 Vaccine Candidates

October 1, 2021 8:00 AM

NOVATO, CA / ACCESSWIRE / October 1, 2021 / Mosaic ImmunoEngineering Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases, today announced that Nicole F. Steinmetz, Ph.D., acting chief scientific officer and co-founder of Mosaic and the director of the UC San Diego Center for...

Read more

enVVeno Medical Corporation Successfully Completes Rebranding

October 1, 2021 7:02 AM

Company Now Trading Under Ticker Symbol "NVNO"IRVINE, CA / ACCESSWIRE / October 1, 2021 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, announced today that it has successfully completed its rebranding and that its shares are now trading under the ticker symbol "NVNO" on The Nasdaq Capital Market. The Company was formerly called Hancock Jaffe...

Read more

Applied UV Announces Laboratory Results Confirm SteriLumen’s Airocide(R) Kills SARS-CoV-2 (COVID-19 Virus)

September 30, 2021 10:40 AM

MOUNT VERNON, NY / ACCESSWIRE / September 30, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced testing results from an independent third-party laboratory confirming...

Read more

Pressure BioSciences UST Platform Successfully Transforms Neem Oil into a Novel, Highly Potent Nanoemulsion for More Effective Agrochemical Applications

September 30, 2021 9:13 AM

Nanoemulsified Neem Oil Droplets Were Designed to Provide Stable, Water-Miscible Concentrates of this Natural, Environmentally Safe Pesticide for Improved Wholesale and Retail UseSOUTH EASTON, MA / ACCESSWIRE / September 30, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide...

Read more

Hemogenyx Pharmaceuticals PLC Announces Half-Year Report

September 30, 2021 3:00 AM

Interim Results for the period ended 30 June 2021LONDON, UK / ACCESSWIRE / September 30, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the StandardListed biopharmaceutical group developing therapies designed to transform blood disease treatment, announces unaudited interim results for the six-month period ended 30 June 2021.All financial amounts are stated in GBP British pounds unless otherwise indicated.Key HighlightsCompleted development...

Read more